Browse Category

Stock Market News 23 December 2025

Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Stock News Today (Dec. 23, 2025): Holiday Spending Data, Stablecoin Settlement Push, and Wall Street Forecasts for V

Visa Inc. (NYSE: V) stock is back in the spotlight on Dec. 23, 2025, as fresh holiday spending data adds new color to the consumer-demand picture—and as investors weigh the payments giant’s fast-moving strategy in stablecoin settlement and AI-driven “agentic commerce.” As of early afternoon Tuesday, Visa shares were modestly higher, trading around $354 (roughly +0.5% on the day), with…
ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

ZIM Integrated Shipping (ZIM) Stock Surges on Competing Buyout Proposals: Latest News, Analyst Targets, Dividend, and 2026 Shipping Outlook

December 23, 2025 — Shares of ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) jumped Tuesday after the company disclosed that its board has received multiple competing proposals to acquire the company’s outstanding shares, escalating a strategic review that has been underway for months. ZIM Investors As of 17:15 UTC on Tuesday, Dec. 23, ZIM traded at $20.96, after touching an…
NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

Dec. 23, 2025 — NexGen Energy Ltd. (TSX: NXE | NYSE: NXE | ASX: NXG) is back in the spotlight as investors weigh a familiar uranium-developer question with very unfamiliar stakes: how close is “close” to a construction decision? TMX Newsfile For NexGen, that question largely funnels into one major catalyst: the Canadian Nuclear Safety Commission (CNSC) process for its…
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics Inc. (NASDAQ: GPCR) is ending 2025 in the middle of one of biotech’s hottest battlegrounds: oral weight-loss medicines. As of Dec. 23, 2025, GPCR shares were trading around $67.50 in U.S. session data, after a volatile stretch driven by blockbuster obesity-trial headlines, a major equity financing, and a wave of analyst price-target updates. Below is a comprehensive roundup…
Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck (MRK) Stock News and Forecasts for Dec. 23, 2025: TrumpRx Pricing Deal, FDA Fast-Track Vouchers, and Wall Street’s Latest Targets

Merck & Co., Inc. (NYSE: MRK) is closing in on year-end with a rare mix of policy-driven headlines, regulatory acceleration, and pipeline catalysts that are shaping investor expectations for 2026 and beyond. From a White House-backed drug-pricing framework that offers tariff relief to drugmakers, to the FDA’s fast-track voucher program attaching itself to two Merck assets with blockbuster potential, MRK…
Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025Bank of AmericaBank of America Stock (NYSE: BAC) News Today: Fed Rate Cuts, Analyst Price Targets, and What Investors Are Watching on Dec. 23, 2025

Bank of America Corporation (NYSE: BAC) stock is trading near its recent highs as 2025 winds down, with investors balancing three big forces: a shifting interest-rate outlook, improving Wall Street deal momentum, and a growing stack of analyst upgrades heading into the bank’s next earnings report. As of Tuesday, December 23, 2025, BAC was trading around $55.96, modestly higher on…
Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp Stock (HUT) Surges on $7B Google-Backed AI Data Center Deal, Street-High $85 Target, and Fresh Analyst Upgrades

Hut 8 Corp (NASDAQ: HUT; TSX: HUT) is back in the market’s spotlight on December 23, 2025, as investors continue to re-rate the company less like a pure-play Bitcoin miner and more like a power-and-data-center platform for the AI era. The stock’s action has been anything but sleepy. After opening sharply lower, shares reversed higher and pushed into the low-to-mid…
Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Stock (INTC) News Today: Price, Analyst Forecasts, and What’s Driving Intel Shares on Dec. 23, 2025

Intel Corporation (NASDAQ: INTC) is ending 2025 in a familiar place for long-time investors—right at the center of a high-stakes debate about what Intel is supposed to be. Is it a classic CPU giant fighting to regain product leadership? A U.S.-anchored foundry champion meant to rival TSMC? Or both at once? On Tuesday, Dec. 23, 2025, that identity question is…
Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

Lionsgate Studios Corp (NYSE: LION) Stock Jumps to New Highs on Dec. 23, 2025: Latest News, Analyst Forecasts, and What’s Driving the Move

December 23, 2025 — Lionsgate Studios Corp stock is having a loud day in the market. Shares of Lionsgate Studios Corp (NYSE: LION) traded around $9.06 Tuesday, up roughly 8%–9%, after touching an intraday high near $9.23 (and a low around $8.54). That price action matters because LION has been flirting with (and now pushing beyond) its prior 52-week high…
Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

Eli Lilly Stock (LLY) Today: Wegovy Pill Approval Raises the Stakes in GLP‑1s as Wall Street Forecasts Point to a High‑Expectation 2026

December 23, 2025 — Eli Lilly and Company stock (NYSE: LLY) is holding near record territory as investors digest a fresh twist in the weight-loss drug race: the FDA has cleared Novo Nordisk’s first oral version of Wegovy, intensifying competition right as Lilly pushes its own once-daily pill candidate, orforglipron, toward a potential 2026 approval. As of 15:11 UTC on…
Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Citigroup Stock (NYSE: C): Regulatory Pressure Eases, Shares Hit New 52‑Week High as Wall Street Maps the 2026 Outlook

Dec. 23, 2025 — Citigroup, Inc. stock is closing out 2025 with a tailwind that investors have been waiting years to see: meaningful signs that long-running regulatory overhangs are starting to lift. Coming into Tuesday’s session, Citi (NYSE: C) was already riding fresh momentum after a strong Monday rally pushed the shares to a new 52‑week high. MarketWatch The year-end…
Costco Stock (COST) Outlook on Dec. 23, 2025: Earnings Beat, Holiday Spending Signals, and Wall Street Forecasts for 2026

Costco Stock (COST) Outlook on Dec. 23, 2025: Earnings Beat, Holiday Spending Signals, and Wall Street Forecasts for 2026

Costco Wholesale Corporation (NASDAQ: COST) is heading into the final stretch of 2025 in a familiar position operationally—strong sales, loyal members, and steady expansion—yet in a less familiar spot in the market: trading close to its 52‑week low after a year of choppy performance. As of Tuesday, Dec. 23, 2025, Costco shares were trading around $853 in late U.S. trading,…

Stock Market Today

  • CVR Energy Shares Dive Nearly 10% on Weak Q4 2025 Outlook
    January 26, 2026, 8:12 PM EST. CVR Energy (CVI) shares plunged nearly 10% on Monday after the company forecasted a significant net loss for Q4 2025, ranging from $105 million to $125 million, a sharp reversal from a net profit of $28 million in Q4 2024. The energy firm's refining throughput hovered around 210,000-220,000 barrels per day, slightly below last year's 214,000 bpd. A major drag came from the fertilizer segment, with ammonia utilization plunging to 60%-65% versus 96% a year ago, reflecting operational struggles at its Coffeyville plant. Despite resolving prior shutdown issues, CVR's overall performance disappointed investors, prompting caution among market watchers.
Go toTop